Multiple myeloma (MM) is unique among hematological malignancies for its association to skeletal destruction causing hypercalcemia, bone pain and increased risk of fractures. MM cells are able to induce a disregulation in the equilibri um between bone formation and bone resorption by recruiting osteoclast (OC) precursors and facilitating osteoclastogenesis. The role of Notch signalling in skeletal development and tis sue remodelling and its hyperactivation in MM prompted us to evaluate if Notch participates in MM -induced osteoclastogenesis. Our results indicate that Notch inhibition impairs MM-mediated OCs differentiation, reducing the frequency and size of TRAP + multinucleated cells. Accordingly Notch p...
Multiple myeloma (MM) is an incurable hematological tumor stemming from malignant plasma cells. MM c...
In multiple myeloma, an overabundance of monoclonal plasma cells in the bone marrow induces localize...
Introduction The Notch pathway dysregulation has been reported in multiple myeloma (MM) and several ...
Multiple myeloma (MM) is unique among hematological malignancies for its association to skeletal des...
Introduction Multiple myeloma (MM) is an incurable hematological tumor stemming from malignant plas...
Introduction The Notch pathway is dysregulated in multiple myeloma (MM), due to the hyperexpression...
Introduction: Multiple myeloma is an incurable hematological tumor stemming from malignant plasma ce...
Multiple myeloma (MM) is closely associated with bone destruction. Once migrated to the bone marrow,...
Background: Bone disease is still a relevant issue in multiple myeloma (MM), since it not only affec...
Multiple myeloma (MM) is a hematologic cancer characterized by uncontrolled growth of malignant plas...
Despite evidence that deregulated Notch signalling is a master regulator of multiple myeloma (MM) pa...
Multiple myeloma (MM) is a deadly hematopoietic malignancy characterized by proliferation of maligna...
Multiple myeloma is a deadly hematopoietic malignancy. Despite therapeutic advances such as autologo...
Background: Multiple myeloma (MM) originates from post-germinal center B cells, and is caused by mal...
Multiple myeloma (MM) is the second most common hematological malignancy, resulting from a clonal pr...
Multiple myeloma (MM) is an incurable hematological tumor stemming from malignant plasma cells. MM c...
In multiple myeloma, an overabundance of monoclonal plasma cells in the bone marrow induces localize...
Introduction The Notch pathway dysregulation has been reported in multiple myeloma (MM) and several ...
Multiple myeloma (MM) is unique among hematological malignancies for its association to skeletal des...
Introduction Multiple myeloma (MM) is an incurable hematological tumor stemming from malignant plas...
Introduction The Notch pathway is dysregulated in multiple myeloma (MM), due to the hyperexpression...
Introduction: Multiple myeloma is an incurable hematological tumor stemming from malignant plasma ce...
Multiple myeloma (MM) is closely associated with bone destruction. Once migrated to the bone marrow,...
Background: Bone disease is still a relevant issue in multiple myeloma (MM), since it not only affec...
Multiple myeloma (MM) is a hematologic cancer characterized by uncontrolled growth of malignant plas...
Despite evidence that deregulated Notch signalling is a master regulator of multiple myeloma (MM) pa...
Multiple myeloma (MM) is a deadly hematopoietic malignancy characterized by proliferation of maligna...
Multiple myeloma is a deadly hematopoietic malignancy. Despite therapeutic advances such as autologo...
Background: Multiple myeloma (MM) originates from post-germinal center B cells, and is caused by mal...
Multiple myeloma (MM) is the second most common hematological malignancy, resulting from a clonal pr...
Multiple myeloma (MM) is an incurable hematological tumor stemming from malignant plasma cells. MM c...
In multiple myeloma, an overabundance of monoclonal plasma cells in the bone marrow induces localize...
Introduction The Notch pathway dysregulation has been reported in multiple myeloma (MM) and several ...